The preconditioning phenomenon: A tool for the scientist or a clinical reality?

Circulation Research

Volumn 87, Issue 7, 2000, Pages 543-550

  Yellon, Derek M ^a,b   Dana, Ali ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Coronary angioplasty; Coronary bypass surgery; Myocardial infarction; Preconditioning; Unstable angina

Indexed keywords

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0034730796     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.7.543     Document Type: Review

References (88)

1. Four brief periods of ischemia cause no cumulative ATP loss or necrosis
2. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
3. Ischemic preconditioning: Present position and future directions
4. Late preconditioning against myocardial stunning: An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs
5. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: An overview
6. Preconditioning of ischemic myocardium: Reperfusion-induced arrhythmias
7. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction
8. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia
9. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia
10. Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia
11. Preconditioning in isolated superfused human muscle
12. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model
13. 1 receptor and K(ATP) channel
14. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium
15. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C
16. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction
17. Previous angina alters in-hospital outcome in TIMI 4: A clinical correlate to preconditioning?
18. Prodromal angina limits infarct size: A role for ischemic preconditioning
19. Association of preceding angina with in-hospital life-threatening ventricular tachyarrhythmias and late potentials in patients with a first acute myocardial infarction
20. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: Acute angiographic findings and long-term prognosis
21. Prospective temporal analysis of the onset of preinfarction angina versus outcome: An ancillary study in TIMI-9B
22. Cardioprotection by preinfarct angina: Is it ischemic preconditioning?
23. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction
24. Ischaemic preconditioning
25. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: Role of adenosine
26. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon
27. Adaptation to the stress of tachycardia in patients with coronary artery disease: Insight into the mechanism of the warm-up phenomenon
28. Attenuation of severity of myocardial ischemia during repeated daily ischemic episodes
29. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: Evidence for cumulative stunning or ischaemic preconditioning?
30. Time course of 'warm-up' in stable angina
31. Mechanisms of the warm-up phenomenon
32. Exercise induced ischemia causes both early and delayed myocardial adaptation during repeated exercise: A role for adenosine?
33. Exercise-induced myocardial ischemia triggers the early phase of preconditioning but not the late phase
34. 1 adenosine receptor blockade on the warm-up phenomenon
35. Effect of theophylline on the warm-up phenomenon
36. Blockade of K(ATP) channels with glibenclamide does not abolish preconditioning during demand ischemia
37. Effects of K(ATP) Channel blockade by glibenclamide on the warm-up phenomenon
38. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic features
39. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study
40. Adaptation to myocardial ischemia during coronary angioplasty demonstrated by clinical, electrocardiographic, echocardiographic, and metabolic parameters
41. Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty
42. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty
43. Beneficial impact of preconditioning during PTCA on creatine kinase release
44. Phentolamine prevents adaptation to ischemia during coronary angioplasty: Role of α-adrenergic receptors in ischemic preconditioning
45. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?
46. + channel blocker
47. Anti-ischemic effects of nicorandil during coronary angioplasty in humans
48. 1 adenosine receptor blockade by bamiphylline on ischemic preconditioning during coronary angioplasty
49. Aminophylline inhibits adaptation to ischemia during coronary angioplasty
50. Preconditioning of human myocardium with adenosine during coronary angioplasty
51. Effects of naloxone on myocardial ischemic preconditioning in humans
52. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty
53. Electrophysiologic characteristics of repetitive ischemic preconditioning in the pig heart
54. Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon
55. S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning
56. Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection
57. Preconditioning the human myocardium
58. Ischemic preconditioning reduces troponin-T release in patients undergoing cardiac surgery
59. Ischemic preconditioning in acute cardiac surgery: A word of caution
60. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning
61. Preconditioning: Can nature's shield be raised against surgical ischemic-reperfusion injury?
62. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia
63. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients
64. Acute myocardial infarction: Thrombolysis
65. Unstable angina pectoris
66. Characterisation of the infarct-limiting effect of delayed preconditioning: Time course and dose-dependency studies in rabbit myocardium
67. Time-course of late preconditioning against myocardial stunning in conscious pigs
68. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning
69. 1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischemic preconditioning in rabbit heart
70. 1 receptor activation maintains rabbit myocardium in a preconditioned state
71. Cardioprotection after repeated dosing with GR79236, an adenosine A1 agonist
72. Cardioprotection by opening of the K(ATP) channel in unstable angina: Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil: CESAR 2 investigation. Clinical European studies in angina and revascularization
73. + channel: A novel therapeutic target in unstable angina?
74. Nicorandil, a potent cardio-protective agent, acts by opening mitochondrial ATP-dependent potassium channels
75. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study
76. Results of percutaneous transluminal coronary angioplasty in unstable angina and non Q-wave myocardial infarction: Observations from the TIMI IIIB Trial
77. Ischemic preconditioning in unstable coronary symptoms: Evidence for time dependence
78. Myocardial revascularization for unstable angina pectoris
79. Troponin-T to diagnose myocardial infarction in bypass surgery
80. Troponin-T: A reliable marker of perioperative myocardial infarction?
81. Ischemic preconditioning enhances donor heart preservation
82. Preconditioning with cromokalim improves long-term myocardial preservation for heart transplantation
83. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
84. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention
85. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators
86. Advances in coronary angioplasty
87. Cardiac metabolism: Emergence, decline, and resurgence, part 2
88. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9461 patients: The PURSUIT investigators